Literature DB >> 30446781

[Partial gland ablation with vascular-targeted phototherapy versus active surveillance for low-risk prostate cancer : Results of a randomized trial].

G Salomon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30446781     DOI： 10.1007/s00120-018-0809-x

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  1 in total

1.  Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.

Authors:  Abdel-Rahmène Azzouzi; Sébastien Vincendeau; Eric Barret; Antony Cicco; François Kleinclauss; Henk G van der Poel; Christian G Stief; Jens Rassweiler; Georg Salomon; Eduardo Solsona; Antonio Alcaraz; Teuvo T Tammela; Derek J Rosario; Francisco Gomez-Veiga; Göran Ahlgren; Fawzi Benzaghou; Bertrand Gaillac; Billy Amzal; Frans M J Debruyne; Gaëlle Fromont; Christian Gratzke; Mark Emberton
Journal:  Lancet Oncol       Date:  2016-12-20       Impact factor: 41.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.